Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT03114865Phase 1/2Active Not Recruiting
A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
Acute Lymphoblastic LeukemiaB-cell Non Hodgkin LymphomaPre B-Cell Acute Lymphoblastic Leukaemia
StudychairStart date: 2017-09-05

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jonathan Webster, MD

Johns Hopkins University

Moderately Similar
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaB-cell Non Hodgkin LymphomaPre B-Cell Acute Lymphoblastic Leukaemia

Worked with same sponsors:

AmgenSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborated on 1 trial
Similarity Score34%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteB-cell Non Hodgkin Lymphoma

Worked with same sponsors:

Amgen
Similarity Score23%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute
Similarity Score15%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Acute
Similarity Score15%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

Merck Sharp & Dohme LLC
Similarity Score15%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Farhad Ravandi-Kashani, MD

M.D. Anderson Cancer Center

Related
14 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Jorge E Cortes, MD

M.D. Anderson Cancer Center

Related
8 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03114865Phase 1/2StudyChair

A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Acute Lymphoblastic LeukemiaB-cell Non Hodgkin LymphomaPre B-Cell Acute Lymphoblastic Leukaemia
Active Not Recruiting
NCT02845297Phase 2PrincipalInvestigator

Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients

Acute Myeloid Leukemia
Completed

All 2 trials loaded